Follow The Filings

JELD JELD-WEN

JELD-WEN earnings company data as of 1:00 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by JELD's executives, directors and 10% owners in the last 12 months, from their Form 4s

All JELD insider trades
  • None no insider bought on the open market
  • $38K sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Samantha Stoddard CFO
    Sale
    $1,776 1,208 shares at $1.47 0.5% of stake
    Traded Jul 2 Filed Jul 6
    ↗
  2. Wendy A. Livingston EVP & CHRO
    Sale
    $3,506 2,435 shares at $1.44 1.4% of stake
    Traded Jun 26 Filed Jun 29
    ↗
  3. Bruce M. Taten Director
    Sale
    $32K 19,483 shares at $1.66 18% of stake
    Traded May 11 Filed May 12
    ↗

Also filed in the last 12 months, not counted as buying or selling: 18 stock grants and 12 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
10-K Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.